Trial
NCT03428945
Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborators
Juvenile Diabetes Research Foundation
Condition
Type1 Diabetes Mellitus
Intervention
Hydroxychloroquine
Why stopped
This trial has undergone a prespecified interim analysis which determined that this treatment provides no statistically significant delay in the onset of abnormal glucose tolerance or Type 1 Diabetes.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-09